Clinical Trial Update: Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin [Phase 4]

View source ↗

Summary

Phase 4 trial update studying the effect of an SGLT2 inhibitor on blood glucose profile in type 2 diabetes patients using basal insulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN